MAGA Senator "Fed Up" With RFK Jr.

The Republican senator whose vote ensured Robert F. Kennedy Jr.’s confirmation as health secretary is now signaling a break.

Sen. Bill Cassidy of Louisiana, a physician and longtime supporter of vaccines, released an 18-page proposal Tuesday calling for a sweeping overhaul of the Food and Drug Administration. The plan demands a top-to-bottom review of the agency’s regulatory structure and urges major modernization efforts.

“Biomedical innovation holds enormous promise for the American people,” Cassidy wrote in his role as chair of the Senate Health, Education, Labor, and Pensions Committee. “But ‘innovation’ is meaningless unless it creates products that actually help patients.”

In the report, Cassidy criticized the FDA for lagging behind scientifically and administratively, arguing that the agency must adopt artificial intelligence and streamline operations to remain effective. The tone suggests growing distance between Cassidy and the Trump administration.

Cassidy’s confirmation vote for Kennedy, despite Kennedy’s history of anti-vaccine activism, was widely interpreted as an attempt to repair his standing with President Trump after voting to impeach him following January 6. Cassidy had previously avoided saying whether Kennedy misrepresented his vaccine positions during confirmation talks.

He has publicly highlighted what he described as a “working relationship” with the president, including posting a photo of himself alongside Trump in the Oval Office. But that relationship appears strained. Last month, Trump endorsed Rep. Julia Letlow in a potential Senate bid against Cassidy, a move that reportedly surprised both Senate Republicans and Letlow herself.

Cassidy responded by affirming his reelection campaign, calling himself “a principled conservative who gets things done for the people of Louisiana.”

While Cassidy has not expressed regret over his vote to confirm Kennedy, he has since pushed back on several of Kennedy’s vaccine-related policies—positions Kennedy had previously indicated would not change.

It is unclear how Kennedy will respond to Cassidy’s FDA overhaul proposal. Notably, five months after requesting Kennedy testify before the Senate health committee, Cassidy has yet to secure an appearance.

Zoom out for a moment. This isn’t just about one confirmation vote. It’s about institutional power. When a physician-senator starts talking about rebuilding the FDA with AI tools and regulatory reform, that’s a signal. Either it’s a policy reset… or it’s a pre-election recalibration. In Washington, those two things often overlap more than people like to admit. 🏛️